These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 6151609)
1. [Genesis of glycoside poisoning in myocardial infarct and its rational pharmacoprevention]. Gendenshteĭn EI; Sernov LN Kardiologiia; 1984 Dec; 24(12):117-21. PubMed ID: 6151609 [No Abstract] [Full Text] [Related]
2. [Clinical correlation between the endocrine system and the cardiovascular system. Beta-adrenergic block in acute myocardial infarct]. Palma G; Nubile G Boll Soc Ital Biol Sper; 1974 Sep; 50(18):1433-9. PubMed ID: 4156473 [No Abstract] [Full Text] [Related]
3. [Various aspects of humoral disorders in recent myocardial infarct and their significance in clinical practice]. Januszewicz W; Sznajderman M Kardiol Pol; 1979; 22(4):473-9. PubMed ID: 40058 [No Abstract] [Full Text] [Related]
4. [EFFICACY OF ANTIARRHYTHMIC AGENTS UNDER CONDITIONS OF STIMULATION OF THE SYMPATHETIC NERVOUS SYSTEM.]. Popova EP; Fisenko VP Eksp Klin Farmakol; 2016; 79(11):26-34. PubMed ID: 29791106 [TBL] [Abstract][Full Text] [Related]
5. [Intervention with beta-blockers in acute myocardial infarct]. Verheugt FW Ned Tijdschr Geneeskd; 1990 Jul; 134(29):1392-4. PubMed ID: 1973825 [No Abstract] [Full Text] [Related]
6. [Pre-hospital period of acute myocardial infarct]. Zilcher H; Kühn P; Kaindl F Wien Z Inn Med; 1973; 54(11-12):496-518. PubMed ID: 4804122 [No Abstract] [Full Text] [Related]
8. [Action of cardiac glycosides and the process of adrenergic mediation (a review of the literature)]. Frantsuzova SB Farmakol Toksikol; 1977; 40(6):733-45. PubMed ID: 23310 [No Abstract] [Full Text] [Related]
13. [Nifedipine in the therapy of myocardial infarct in patients over 70]. Ziacchi V; Rossi A; Lomanto B Minerva Cardioangiol; 1982 Apr; 30(4):163-9. PubMed ID: 6123963 [No Abstract] [Full Text] [Related]
14. [Sympathico-adrenal system in myocardial infarct]. Koziara Z Pol Tyg Lek; 1971 Jun; 26(26):1007-10. PubMed ID: 4997968 [No Abstract] [Full Text] [Related]
15. Exercise tolerance and compensatory sympathetic tone during beta-blockade after myocardial infarction. Brice G; Stone HL Med Sci Sports Exerc; 1986 Aug; 18(4):396-401. PubMed ID: 2875377 [TBL] [Abstract][Full Text] [Related]
16. [Recent aspects on basic drug therapy of acute myocardial infarct]. Erbel R; Belz GG Med Klin; 1977 Sep; 72(35):1341-60. PubMed ID: 20560 [No Abstract] [Full Text] [Related]
17. Question of norepinephrine release in the action of cardiac glycosides. Gillis RA Circ Res; 1971 Jul; 29(1):104-6. PubMed ID: 4397821 [No Abstract] [Full Text] [Related]
18. [Sympathetico-adrenergic system activity in relation to the development of cardiac arrhythmias in patients with acute myocardial infarct]. Fu YF Sheng Li Ke Xue Jin Zhan; 1983 Jan; 14(1):67-70. PubMed ID: 6304874 [No Abstract] [Full Text] [Related]
19. [Some aspects of the use of prolonged neuroplegia in treating acute myocardial infarct]. Gvatua NA; Kravtsov VL; Tsyganii AA; Pomerantsev IuV; Ianovskii AD Kardiologiia; 1973 Apr; 13(4):35-43. PubMed ID: 4711312 [No Abstract] [Full Text] [Related]
20. [Prevention of sudden death in myocardial infarct: do experimental results help to understand the clinical reality? The case of the clinical trial SWORD (Survival With ORal D-sotalol)]. Schwartz PJ Cardiologia; 1996 Aug; 41(8):739-45. PubMed ID: 8925528 [No Abstract] [Full Text] [Related] [Next] [New Search]